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ABSTRACT 
Background: Benign prostatic hyperplasia (BPH) is the common benign 
tumor  in  men  more  than  50  years  of  age.  5  α reductase  inhibitors  like  
Finasteride and Dutasteride are commonly used in the medical 
management  of  BPH  due  to  its  prostatic  volume  reduction  properties  
secondary to inhibition of the androgen Dihydro- testosterone. Studies 
have reported that short course of preoperative Finasteride reduces the 
peri-operative blood loss following TURP for BPH. But this is not 
practiced widely. Therefore we conducted this study to evaluate the effect 
of finasteride on intra-operative and postoperative blood loss following 
TURP, which could resolve some of the controversies over the use of this 
drug. 
Methods: one Hundred patients undergoing TURP for BPH were 
randomly allocated in to two groups with 50 patients in each group. Group 
A patients received tablet finasteride 5 milligram once a day 2 weeks prior 
to surgery and group B patients received only placebo. Intraoperative 
blood loss, post operative hemoglobin, PCV drops and operative time, 
resected tissue weight and tissue microvessel density was assessed. Post 
operative follow- up was done at one month maximum urinary flow rate 
and IPSS score was assessed. 
Results: The demographic parameters were comparable in two groups. 
The mean hemoglobin drop in group A & B was 1.7 and 2.8 grams 
respectively. The mean operative time and resected tissue weight in both 
group A &B were 46 minutes, 27.7 grams & 53 minutes, 24.1 grams 
respectively. In finasteride group there was significant reduction of 
Intraoperative blood loss, microvessel density and post operative 
complications like clot retention, need for blood transfusion and urinary 
tract infection.  
Conclusion: preoperative short course finasteride therapy definitely 
reduces the peri-operative blood loss following TURP for BPH. 
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